About: Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $7.64 (+3.66%)
EOLS NASDAQ Evolus Inc
Evolus Inc share price
Atividade de preço de EOLS
Último preço
$ 7,640
Variação (24h)
0,27 USD (3,66%)
Volume
320.50K
Volume (média 4 sem.)
-
Abertura
$ 7,38
Variação do dia
$ 7,30 - $ 7,71
Fechamento anterior
$ 7,37
Último negócio
28 Oct, 6:42 pm GMT+0
Atrasado
28 Oct, 6:42 pm GMT+0
EOLS price performance
Atrasado
28 Oct, 6:42 pm GMT+0
quote.marketSignals